Skip to main content
Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS · Delayed Price · Currency is USD
0.740
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST

Fresh Tracks Therapeutics Revenue

In the year 2023, Fresh Tracks Therapeutics had annual revenue of $8.01M with 15.31% growth.

Revenue
8.01M
Revenue Growth
+15.31%
P/S Ratio
0.50
Revenue / Employee
2.00M
Employees
4
Market Cap
4.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.01M1.06M15.31%
Dec 31, 20226.94M6.54M1,618.56%
Dec 31, 2021404.00K-1.42M-77.83%
Dec 31, 20201.82M-6.10M-76.99%
Dec 31, 20197.92M-2.97M-27.29%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sandoz Group AG 10.11B
Telix Pharmaceuticals Limited 430.80M
Elekta AB (publ) 1.66B
Ryman Healthcare Limited 458.44M
Verano Holdings Corp. 897.57M
Vireo Growth Inc. 98.53M
Medexus Pharmaceuticals Inc. 104.76M
Revenue Rankings

Fresh Tracks Therapeutics News

More News